In a recent Form 13F-HR/A filed with the U.S. Securities and Exchange Commission, New York-based Two Sigma Advisers, LP disclosed that it boosted up its stake in one Canadian cannabis producer, Aphria Inc. (TSX:APHA) (NASDAQ:APHA) (FRA:10E), and dumped its shares of others including Aurora Cannabis (TSX:ACB) (NYSE:ACB) (FRA:21P), Canopy Growth Corp. (TSX:WEED) (NYSE:CGC) (FRA:11L1), and Tilray Inc. (NASDAQ:TLRY) (FRA:2HQ).
Here’s what marijuana investors need to know…
According to Bloomberg, “Two Sigma Advisers serves customers worldwide.” With an over $85 billion in assets under management as of a recent Form ADV, Two Sigma Advisers, LP’ is a behemoth.
According to SEC filings, Two Sigma previously held 17,200 shares of APHA, but after its purchase of an additional 113,400 shares of Aphria Inc. it raised its stake to 130,600 shares.
As for its Aurora position – what was once a solid 65,469 shares of ACB is now zero it seems. Two Sigma also sold off its entire 29,200 share position in CGC, and its 16,300 shares of TLRY..
The rotation among the Canadian LP stocks is the noteworthy takeaway here. After all, shares of Aurora are down -72.96% on a year-to-date basis, Canopy was down -21.86% YTD, and Tilray was down -67.08% YTD.
Shares of APHA on the other hand were down -11.30% over the same period.
While every investor would love to be up on the year, when compared to its peers, shares of Aphria are the comparative winner for sure.
We’ll continue to monitor 13F filings to see what institutional investors are up to. In the meantime, be sure to subscribe to cannabis stock updates here so you never miss an important update.
Get Real-Time Updates from MJobserver.com